Global Chlamydia Diagnosis and Treatment Market Research and Forecast 2018-2023

Posted by Orion Market Research on September 4th, 2018

Chlamydia trachomatis is a type of sexually transmitted disease that is prevalent in population of all age group, but women are much more vulnerable to it. The Chlamydia diagnosis involves a series of test such as urine culture, Nucleic acid amplification tests, Enzyme immunoassays and so on. The change in lifestyle especially related to sex preferences is the major factor driving the growth of this market, moreover, the increase in use of rapid point of care diagnosis kits also propel the market. The treatment of this disease is prolonged and usually achieved by administration of oral antibiotics to the patients. The lack of skilled practitioners for performing diagnostic test and the high cost of the tests such as Nucleic acid amplification test is the major factor for growth hindrance of market. The awareness, supportive government regulations and increased funding on development of novel diagnostic method will drive the growth of chlamydia diagnosis market in the forecasted period.

Browse full report at: Global Chlamydia Diagnosis and Treatment Market

The market is divided into North America, Europe, Asia Pacific and Rest of the World geographically. North America region captures the major market share of Chlamydia diagnosis and treatment market due to high prevalence of disease in the region. The region also has leading diagnostic companies making it the most revenue generating region. The APAC region will grow significantly in the projected period due to rapid development in the economies and large investment in healthcare sector. The European region also holds the substantial share of the Chlamydia Diagnosis market.

The competition in Chlamydia Diagnosis market is moderate as relatively low number of companies are present in the segment, the market players are engaged in providing diagnostic tests such as Nucleic acid amplification test, Enzyme immunoassays test and rapid diagnostic test kits. The Key Players in the Chlamydia Diagnosis market are Abbott Laboratories, Hologic Inc, Laboratory Corporation of America, Novartis Diagnostics, Qiagen, Quidel Corporation, Roche Molecular Systems Inc., Siemens AG, Synapse Diagnostics, Sysmex corporation, Thermo Fisher Scientific, Tosoh Corporation and so on. The companies are also engaged in rapid research and development for the development of rapid diagnostic test kits for effective diagnosis of the disease.

Related Reports: Healthcare Industry Research